Comments on the guidelines (2023) of the ESC on the management of cardiovascular diseases in patients with diabetes

被引：0

作者：

Marx, Nikolaus ^{[1
]}

Mueller-Wieland, Dirk ^{[1
]}

Espinola-Klein, Christine ^{[2
]}

Halle, Martin ^{[3
]}

Birkenhagen, Annette ^{[4
]}

Diemert, Patrick ^{[5
]}

Mahfoud, Felix ^{[6
,9
]}

Wienbergen, Harm ^{[7
,8
]}

Schuett, Katharina ^{[1
]}

机构：

[1] Uniklin RTWH Aachen, Med Klin Kardiol Angiol & Internist Intensivmed 1, Pauwelsstr 30, D-52074 Aachen, Germany

[2] Univ Med Mainz, Zent Kardiol, Kardiol Angiol 3, Mainz, Germany

[3] Tech Univ Munich, TUM Sch Med & Hlth, Pravent Sportmed & Sportkardiol, TUM Univ klinikum rechts Isar, Munich, Germany

[4] Kardiol Angiol Praxis, Stollberg, Germany

[5] Univ Herz & Gefasszentrum Hamburg, Klinik & Poliklin Kardiol, Hamburg, Germany

[6] Univ klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intensi, Homburg, Germany

[7] Bremer Inst Herz & Kreislaufforsch, Stiftung Bremer Herzen, Gesundheit Nord Klinikverbund Bremen, Bremen, Germany

[8] Univ Lubeck, Med Klin 2, Lubeck, Germany

[9] Deutsch Gesell Kardiol Herz & Kreislaufforsch eV D, Kommiss Klin Kardiovask Med, Dusseldorf, Germany

来源：

KARDIOLOGIE | 2024年 / 18卷 / 03期

关键词：

Diabetes mellitus; Cardiovascular disease; Heart failure; Kidney failure; EJECTION FRACTION; KIDNEY OUTCOMES; HEART-FAILURE; TYPE-2; EMPAGLIFLOZIN; METAANALYSIS; FINERENONE; MORTALITY;

D O I：

10.1007/s12181-024-00689-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with diabetes mellitus exhibit an increased risk for the development of cardiovascular diseases and the presence of both comorbidities has a major impact not only on the prognosis but also the implementation of evidence-based treatment to reduce the cardiovascular risk. The new 2023 guidelines of the European Society of Cardiology (ESC) provide firm evidence-based recommendations for the management of cardiovascular diseases in patients with diabetes. The most relevant aspects of these guidelines are summarized in the following overview article.

引用

页码：256 / 265

页数：10

共 28 条

[1] Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis [J].

Agarwal, Rajiv ;

Filippatos, Gerasimos ;

Pitt, Bertram ;

Anker, Stefan D. ;

Rossing, Peter ;

Joseph, Amer ;

Kolkhof, Peter ;

Nowack, Christina ;

Gebel, Martin ;

Ruilope, Luis M. ;

Bakris, George L. .

EUROPEAN HEART JOURNAL, 2022, 43 (06) :474-+

[2] Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Ferreira, Joao P. ;

Bocchi, Edimar ;

Boehm, Michael ;

Brunner-La Rocca, Hans-Peter ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure-Valenzuela, Eduardo ;

Giannetti, Nadia ;

Gomez-Mesa, Juan Esteban ;

Janssens, Stefan ;

Januzzi, James L. ;

Gonzalez-Juanatey, Jose R. ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio V. ;

Pina, Ileana L. ;

Ponikowski, Piotr ;

Senni, Michele ;

Sim, David ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Vinereanu, Dragos ;

Zhang, Jian ;

Carson, Peter ;

Lam, Carolyn Su Ping ;

Marx, Nikolaus ;

Zeller, Cordula ;

Sattar, Naveed ;

Jamal, Waheed ;

Schnaidt, Sven ;

Schnee, Janet M. ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461

[3] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].

Bakris, George L. ;

Agarwal, Rajiv ;

Anker, Stefan D. ;

Pitt, Bertram ;

Ruilope, Luis M. ;

Rossing, Peter ;

Kolkhof, Peter ;

Nowack, Christina ;

Schloemer, Patrick ;

Joseph, Amer ;

Filippatos, Gerasimos .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229

[4] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease [J].

Bhatt, Deepak L. ;

Szarek, Michael ;

Pitt, Bertram ;

Cannon, Christopher P. ;

Leiter, Lawrence A. ;

McGuire, Darren K. ;

Lewis, Julia B. ;

Riddle, Matthew C. ;

Inzucchi, Silvio E. ;

Kosiborod, Mikhail N. ;

Cherney, David Z. I. ;

Dwyer, Jamie P. ;

Scirica, Benjamin M. ;

Bailey, Clifford J. ;

Diaz, Rafael ;

Ray, Kausik K. ;

Udell, Jacob A. ;

Lopes, Renato D. ;

Lapuerta, Pablo ;

Steg, P. Gabriel .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) :129-139

[5]

Cosentino F., 2020, EUR HEART J, V41, P255, DOI DOI 10.1093/EURHEARTJ/EHZ486

[6] Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes [J].

Filippatos, Gerasimos ;

Butler, Javed ;

Farmakis, Dimitrios ;

Zannad, Faiez ;

Ofstad, Anne Pernille ;

Ferreira, Joao Pedro ;

Green, Jennifer B. ;

Rosenstock, Julio ;

Schnaidt, Sven ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Packer, Milton ;

Anker, Stefan D. .

CIRCULATION, 2022, 146 (09) :676-686

[7] Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes [J].

Gerstein, Hertzel C. ;

Sattar, Naveed ;

Rosenstock, Julio ;

Ramasundarahettige, Chinthanie ;

Pratley, Richard ;

Lopes, Renato D. ;

Lam, Carolyn S. P. ;

Khurmi, Nardev S. ;

Heenan, Laura ;

Del Prato, Stefano ;

Dyal, Leanne ;

Branch, Kelley .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10) :896-907

[8] Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial [J].

Gerstein, Hertzel C. ;

Colhoun, Helen M. ;

Dagenais, Gilles R. ;

Diaz, Rafael ;

Lakshmanan, Mark ;

Pais, Prem ;

Probstfield, Jeffrey ;

Riesmeyer, Jeffrey S. ;

Riddle, Matthew C. ;

Ryden, Lars ;

Xavier, Denis ;

Atisso, Charles Messan ;

Dyal, Leanne ;

Hall, Stephanie ;

Rao-Melacini, Purnima ;

Wong, Gloria ;

Avezum, Alvaro ;

Basile, Jan ;

Chung, Namsik ;

Conget, Ignacio ;

Cushman, William C. ;

Franek, Edward ;

Hancu, Nicolae ;

Hanefeld, Markolf ;

Holt, Shaun ;

Jansky, Petr ;

Keltai, Matyas ;

Lanas, Fernando ;

Leiter, Lawrence A. ;

Lopez-Jaramillo, Patricio ;

Cardona Munoz, Ernesto German ;

Pirags, Valdis ;

Pogosova, Nana ;

Raubenheimer, Peter J. ;

Shaw, Jonathan E. ;

Sheu, Wayne H-H ;

Temelkova-Kurktschiev, Theodora .

LANCET, 2019, 394 (10193) :121-130

[9] Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial [J].

Hernandez, Adrian F. ;

Green, Jennifer B. ;

Janmohamed, Salim ;

D'Agostino, Ralph B., Sr. ;

Granger, Christopher B. ;

Jones, Nigel P. ;

Leiter, Lawrence A. ;

Rosenberg, Anne E. ;

Sigmon, Kristina N. ;

Somerville, Matthew C. ;

Thorpe, Karl M. ;

McMurray, John J. V. ;

Del Prato, Stefano .

LANCET, 2018, 392 (10157) :1519-1529

[10] Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes [J].

Holman, Rury R. ;

Bethel, M. Angelyn ;

Mentz, Robert J. ;

Thompson, Vivian P. ;

Lokhnygina, Yuliya ;

Buse, John B. ;

Chan, Juliana C. ;

Choi, Jasmine ;

Gustavson, Stephanie M. ;

Iqbal, Nayyar ;

Maggioni, Aldo P. ;

Marso, Steven P. ;

Ohman, Peter ;

Pagidipati, Neha J. ;

Poulter, Neil ;

Ramachandran, Ambady ;

Zinman, Bernard ;

Hernandez, Adrian F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (13) :1228-1239

← 1 2 3 →